Report Detail

Request for Sample of this report

Other Global GMP Viral Vector Manufacturing Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4568607
    • |
  • 08 December, 2023
    • |
  • Global
    • |
  • 140 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Other

According to our (Global Info Research) latest study, the global GMP Viral Vector Manufacturing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
GMP viral vector manufacturing is the manufacturing of viral vectors, such as adenoviruses or lentiviruses, under Good Manufacturing Practices (GMP) standards for use in gene therapy and vaccine production. This process ensures the safety and quality of the viral vectors for medical applications.
The Global Info Research report includes an overview of the development of the GMP Viral Vector Manufacturing industry chain, the market status of Clinical Research (Adenovirus Vector Manufacturing, AAV Vector Manufacturing), Commercial Production (Adenovirus Vector Manufacturing, AAV Vector Manufacturing), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of GMP Viral Vector Manufacturing.
Regionally, the report analyzes the GMP Viral Vector Manufacturing markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global GMP Viral Vector Manufacturing market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the GMP Viral Vector Manufacturing market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the GMP Viral Vector Manufacturing industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Adenovirus Vector Manufacturing, AAV Vector Manufacturing).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the GMP Viral Vector Manufacturing market.
Regional Analysis: The report involves examining the GMP Viral Vector Manufacturing market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the GMP Viral Vector Manufacturing market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to GMP Viral Vector Manufacturing:
Company Analysis: Report covers individual GMP Viral Vector Manufacturing manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards GMP Viral Vector Manufacturing This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Clinical Research, Commercial Production).
Technology Analysis: Report covers specific technologies relevant to GMP Viral Vector Manufacturing. It assesses the current state, advancements, and potential future developments in GMP Viral Vector Manufacturing areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the GMP Viral Vector Manufacturing market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
GMP Viral Vector Manufacturing market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Adenovirus Vector Manufacturing
AAV Vector Manufacturing
Retroviral Vector Manufacturing
Lentiviral Vector Manufacturing
Others
Market segment by Application
Clinical Research
Commercial Production
Others
Major players covered
Advanced BioScience Laboratories
Biovian
Lonza
Takara Bio
Genezen
Halix
Merck
Batavia Biosciences
Exothera
WuXi Biologics
Vectorbuilder
Abace-Biology
Genscript
Cytiva
Obiosh
Pregene
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe GMP Viral Vector Manufacturing product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of GMP Viral Vector Manufacturing, with price, sales, revenue and global market share of GMP Viral Vector Manufacturing from 2018 to 2023.
Chapter 3, the GMP Viral Vector Manufacturing competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the GMP Viral Vector Manufacturing breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and GMP Viral Vector Manufacturing market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of GMP Viral Vector Manufacturing.
Chapter 14 and 15, to describe GMP Viral Vector Manufacturing sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of GMP Viral Vector Manufacturing
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global GMP Viral Vector Manufacturing Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Adenovirus Vector Manufacturing
    • 1.3.3 AAV Vector Manufacturing
    • 1.3.4 Retroviral Vector Manufacturing
    • 1.3.5 Lentiviral Vector Manufacturing
    • 1.3.6 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global GMP Viral Vector Manufacturing Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Clinical Research
    • 1.4.3 Commercial Production
    • 1.4.4 Others
  • 1.5 Global GMP Viral Vector Manufacturing Market Size & Forecast
    • 1.5.1 Global GMP Viral Vector Manufacturing Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global GMP Viral Vector Manufacturing Sales Quantity (2018-2029)
    • 1.5.3 Global GMP Viral Vector Manufacturing Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Advanced BioScience Laboratories
    • 2.1.1 Advanced BioScience Laboratories Details
    • 2.1.2 Advanced BioScience Laboratories Major Business
    • 2.1.3 Advanced BioScience Laboratories GMP Viral Vector Manufacturing Product and Services
    • 2.1.4 Advanced BioScience Laboratories GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Advanced BioScience Laboratories Recent Developments/Updates
  • 2.2 Biovian
    • 2.2.1 Biovian Details
    • 2.2.2 Biovian Major Business
    • 2.2.3 Biovian GMP Viral Vector Manufacturing Product and Services
    • 2.2.4 Biovian GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Biovian Recent Developments/Updates
  • 2.3 Lonza
    • 2.3.1 Lonza Details
    • 2.3.2 Lonza Major Business
    • 2.3.3 Lonza GMP Viral Vector Manufacturing Product and Services
    • 2.3.4 Lonza GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Lonza Recent Developments/Updates
  • 2.4 Takara Bio
    • 2.4.1 Takara Bio Details
    • 2.4.2 Takara Bio Major Business
    • 2.4.3 Takara Bio GMP Viral Vector Manufacturing Product and Services
    • 2.4.4 Takara Bio GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Takara Bio Recent Developments/Updates
  • 2.5 Genezen
    • 2.5.1 Genezen Details
    • 2.5.2 Genezen Major Business
    • 2.5.3 Genezen GMP Viral Vector Manufacturing Product and Services
    • 2.5.4 Genezen GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Genezen Recent Developments/Updates
  • 2.6 Halix
    • 2.6.1 Halix Details
    • 2.6.2 Halix Major Business
    • 2.6.3 Halix GMP Viral Vector Manufacturing Product and Services
    • 2.6.4 Halix GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Halix Recent Developments/Updates
  • 2.7 Merck
    • 2.7.1 Merck Details
    • 2.7.2 Merck Major Business
    • 2.7.3 Merck GMP Viral Vector Manufacturing Product and Services
    • 2.7.4 Merck GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Merck Recent Developments/Updates
  • 2.8 Batavia Biosciences
    • 2.8.1 Batavia Biosciences Details
    • 2.8.2 Batavia Biosciences Major Business
    • 2.8.3 Batavia Biosciences GMP Viral Vector Manufacturing Product and Services
    • 2.8.4 Batavia Biosciences GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Batavia Biosciences Recent Developments/Updates
  • 2.9 Exothera
    • 2.9.1 Exothera Details
    • 2.9.2 Exothera Major Business
    • 2.9.3 Exothera GMP Viral Vector Manufacturing Product and Services
    • 2.9.4 Exothera GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Exothera Recent Developments/Updates
  • 2.10 WuXi Biologics
    • 2.10.1 WuXi Biologics Details
    • 2.10.2 WuXi Biologics Major Business
    • 2.10.3 WuXi Biologics GMP Viral Vector Manufacturing Product and Services
    • 2.10.4 WuXi Biologics GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 WuXi Biologics Recent Developments/Updates
  • 2.11 Vectorbuilder
    • 2.11.1 Vectorbuilder Details
    • 2.11.2 Vectorbuilder Major Business
    • 2.11.3 Vectorbuilder GMP Viral Vector Manufacturing Product and Services
    • 2.11.4 Vectorbuilder GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Vectorbuilder Recent Developments/Updates
  • 2.12 Abace-Biology
    • 2.12.1 Abace-Biology Details
    • 2.12.2 Abace-Biology Major Business
    • 2.12.3 Abace-Biology GMP Viral Vector Manufacturing Product and Services
    • 2.12.4 Abace-Biology GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Abace-Biology Recent Developments/Updates
  • 2.13 Genscript
    • 2.13.1 Genscript Details
    • 2.13.2 Genscript Major Business
    • 2.13.3 Genscript GMP Viral Vector Manufacturing Product and Services
    • 2.13.4 Genscript GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Genscript Recent Developments/Updates
  • 2.14 Cytiva
    • 2.14.1 Cytiva Details
    • 2.14.2 Cytiva Major Business
    • 2.14.3 Cytiva GMP Viral Vector Manufacturing Product and Services
    • 2.14.4 Cytiva GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Cytiva Recent Developments/Updates
  • 2.15 Obiosh
    • 2.15.1 Obiosh Details
    • 2.15.2 Obiosh Major Business
    • 2.15.3 Obiosh GMP Viral Vector Manufacturing Product and Services
    • 2.15.4 Obiosh GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Obiosh Recent Developments/Updates
  • 2.16 Pregene
    • 2.16.1 Pregene Details
    • 2.16.2 Pregene Major Business
    • 2.16.3 Pregene GMP Viral Vector Manufacturing Product and Services
    • 2.16.4 Pregene GMP Viral Vector Manufacturing Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Pregene Recent Developments/Updates

3 Competitive Environment: GMP Viral Vector Manufacturing by Manufacturer

  • 3.1 Global GMP Viral Vector Manufacturing Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global GMP Viral Vector Manufacturing Revenue by Manufacturer (2018-2023)
  • 3.3 Global GMP Viral Vector Manufacturing Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of GMP Viral Vector Manufacturing by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 GMP Viral Vector Manufacturing Manufacturer Market Share in 2022
    • 3.4.2 Top 6 GMP Viral Vector Manufacturing Manufacturer Market Share in 2022
  • 3.5 GMP Viral Vector Manufacturing Market: Overall Company Footprint Analysis
    • 3.5.1 GMP Viral Vector Manufacturing Market: Region Footprint
    • 3.5.2 GMP Viral Vector Manufacturing Market: Company Product Type Footprint
    • 3.5.3 GMP Viral Vector Manufacturing Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global GMP Viral Vector Manufacturing Market Size by Region
    • 4.1.1 Global GMP Viral Vector Manufacturing Sales Quantity by Region (2018-2029)
    • 4.1.2 Global GMP Viral Vector Manufacturing Consumption Value by Region (2018-2029)
    • 4.1.3 Global GMP Viral Vector Manufacturing Average Price by Region (2018-2029)
  • 4.2 North America GMP Viral Vector Manufacturing Consumption Value (2018-2029)
  • 4.3 Europe GMP Viral Vector Manufacturing Consumption Value (2018-2029)
  • 4.4 Asia-Pacific GMP Viral Vector Manufacturing Consumption Value (2018-2029)
  • 4.5 South America GMP Viral Vector Manufacturing Consumption Value (2018-2029)
  • 4.6 Middle East and Africa GMP Viral Vector Manufacturing Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global GMP Viral Vector Manufacturing Sales Quantity by Type (2018-2029)
  • 5.2 Global GMP Viral Vector Manufacturing Consumption Value by Type (2018-2029)
  • 5.3 Global GMP Viral Vector Manufacturing Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global GMP Viral Vector Manufacturing Sales Quantity by Application (2018-2029)
  • 6.2 Global GMP Viral Vector Manufacturing Consumption Value by Application (2018-2029)
  • 6.3 Global GMP Viral Vector Manufacturing Average Price by Application (2018-2029)

7 North America

  • 7.1 North America GMP Viral Vector Manufacturing Sales Quantity by Type (2018-2029)
  • 7.2 North America GMP Viral Vector Manufacturing Sales Quantity by Application (2018-2029)
  • 7.3 North America GMP Viral Vector Manufacturing Market Size by Country
    • 7.3.1 North America GMP Viral Vector Manufacturing Sales Quantity by Country (2018-2029)
    • 7.3.2 North America GMP Viral Vector Manufacturing Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe GMP Viral Vector Manufacturing Sales Quantity by Type (2018-2029)
  • 8.2 Europe GMP Viral Vector Manufacturing Sales Quantity by Application (2018-2029)
  • 8.3 Europe GMP Viral Vector Manufacturing Market Size by Country
    • 8.3.1 Europe GMP Viral Vector Manufacturing Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe GMP Viral Vector Manufacturing Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific GMP Viral Vector Manufacturing Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific GMP Viral Vector Manufacturing Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific GMP Viral Vector Manufacturing Market Size by Region
    • 9.3.1 Asia-Pacific GMP Viral Vector Manufacturing Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific GMP Viral Vector Manufacturing Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America GMP Viral Vector Manufacturing Sales Quantity by Type (2018-2029)
  • 10.2 South America GMP Viral Vector Manufacturing Sales Quantity by Application (2018-2029)
  • 10.3 South America GMP Viral Vector Manufacturing Market Size by Country
    • 10.3.1 South America GMP Viral Vector Manufacturing Sales Quantity by Country (2018-2029)
    • 10.3.2 South America GMP Viral Vector Manufacturing Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa GMP Viral Vector Manufacturing Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa GMP Viral Vector Manufacturing Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa GMP Viral Vector Manufacturing Market Size by Country
    • 11.3.1 Middle East & Africa GMP Viral Vector Manufacturing Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa GMP Viral Vector Manufacturing Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 GMP Viral Vector Manufacturing Market Drivers
  • 12.2 GMP Viral Vector Manufacturing Market Restraints
  • 12.3 GMP Viral Vector Manufacturing Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of GMP Viral Vector Manufacturing and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of GMP Viral Vector Manufacturing
  • 13.3 GMP Viral Vector Manufacturing Production Process
  • 13.4 GMP Viral Vector Manufacturing Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 GMP Viral Vector Manufacturing Typical Distributors
  • 14.3 GMP Viral Vector Manufacturing Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on GMP Viral Vector Manufacturing. Industry analysis & Market Report on GMP Viral Vector Manufacturing is a syndicated market report, published as Global GMP Viral Vector Manufacturing Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of GMP Viral Vector Manufacturing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,780.52
    		4,170.78
    		5,561.04
    		3,229.44
    		4,844.16
    		6,458.88
    		542,392.80
    		813,589.20
    		1,084,785.60
    		290,823.60
    		436,235.40
    		581,647.20
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo